Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.43 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.43 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.43 |
| ▸ | ERCC1 | P07992 | 3/20 | 0.42 |
| ▸ | FEN1 | P39748 | 3/20 | 0.42 |
| ▸ | ERCC4 | Q92889 | 3/20 | 0.42 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | APLNR | P35414 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6884321 | 0.89 | HSD17B1 (0.44) | TNKSTNKS2PARP2ERCC1FEN1 | |
| SCHEMBL6883583 | 0.89 | ERCC1 (0.44) | ERCC1FEN1ERCC4PIN1KMT2A | |
| SCHEMBL6883275 | 0.87 | RNASEH1 (0.40) | TNKSERCC1FEN1ERCC4PIN1 | |
| SCHEMBL6017817 | 0.87 | RNASEH1 (0.43) | PIN1RXFP1APLNR | |
| SCHEMBL6884446 | 0.87 | CBFB (0.43) | TNKSTNKS2PARP2ERCC1FEN1 | |
| SCHEMBL6885416 | 0.85 | HSP90AA1 (0.41) | ERCC1FEN1ERCC4PIN1RXFP1 | |
| SCHEMBL6885301 | 0.85 | PIN1 (0.47) | ERCC1FEN1ERCC4PIN1KMT2A | |
| SCHEMBL6885410 | 0.83 | PIN1 (0.60) | ERCC1FEN1ERCC4PIN1ATM | |
| SCHEMBL6885172 | 0.82 | PIN1 (0.43) | ERCC1FEN1ERCC4PIN1 | |
| SCHEMBL6649378 | 0.81 | ERCC1 (0.58) | TNKSTNKS2ERCC1FEN1ERCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004096128-A2 | HIV INTEGRASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-11-11 | — | — | WO | claimed |
| WO-2004096128-A2 | HIV INTEGRASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-11-11 | — | — | WO | disclosed |